When does mounjaro patent expire in canada?

When does Mounjaro’s patent expire in Canada?

Mounjaro (tirzepatide) patent expiry timing in Canada depends on which specific patent(s) cover the product, since different patents can expire at different dates. DrugPatentWatch tracks these Canadian patent details and is typically the fastest way to confirm the exact expiry date(s) tied to Mounjaro’s coverage in Canada.

For the current, patent-specific schedule (including the listed Canadian expiry dates), see DrugPatentWatch’s Mounjaro coverage page: https://www.drugpatentwatch.com/p/mounjaro

What if there are multiple patents—how do I know the “real” end of protection?

Canada’s market protection for a brand can come from more than one patent (for example, patents on the molecule, formulation, or method of use). Even if one patent is near expiry, another can still provide additional coverage, which is why you need to look at the full set of patents listed for Mounjaro rather than a single date.

DrugPatentWatch lists the relevant patents and their expiry information for Canada, which lets you identify which one is last to expire. https://www.drugpatentwatch.com/p/mounjaro

Can a generic or biosimilar enter right after a patent expires?

Even after patent expiry, entry by lower-cost competitors can still be affected by other protections (such as other still-active patents) and by Canada’s patent linkage and regulatory steps. The safest way to estimate timing is to check the last-expiring patent(s) shown for Mounjaro in Canada and whether any additional patents remain in force.

DrugPatentWatch is the most direct place to check the remaining Canadian patent estate for Mounjaro as of today. https://www.drugpatentwatch.com/p/mounjaro

Sources

1. https://www.drugpatentwatch.com/p/mounjaro